Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (429)

Latest Posts

About This Stock More About This Stock
AskSlim Market Week - Saturday, Jan. 5
Video By: Steve Miller
Saturday, January 5, 2019 4:19 PM EST
The stock market began the New Year with huge movements leaving investors jittery as some still call for a bear market and other worry they'll miss huge rallies.
In this video: GILD, BRK-A, AAPL, SPX
Five Stocks To Add In 2019
Article By: Andreas Gruener
Sunday, December 30, 2018 1:33 PM EST
December 2018 is on its way to be one of the worst months ever in the history of the Dow Jones. But this just means there are plenty of new buying opportunities out there.
In this article: ITW, PRU, XOM, AVGO, GILD
January 2019 Stock Considerations
Article By: Keith Park
Sunday, December 30, 2018 11:09 AM EST
With a highly volatile ending to 2018 we have no shortage of quality dividend stocks to choose from. With that being said, let’s take a look at my January 2019 potential stock picks.
In this article: CAH, MO, PM, T, GILD
Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates
Article By: ChinaBio® Today
Saturday, November 24, 2018 4:09 PM EST
Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.
In this article: LLY, CASI, BIIB, GILD
Gilead Selloff On UnitedHeath HIV Promotion Seen As Unwarranted
Article By: The Fly
Wednesday, October 31, 2018 5:11 PM EST
In afternoon trading, shares of Gilead have dropped about 5% to $68.65.
In this article: GILD, UNH


Latest Tweets for $GILD

No tweets yet!


Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments